about
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenanceThe impact of intra-clonal heterogeneity on the treatment of multiple myeloma.Second primary malignancies and myeloma therapy: fad or fact?Lenalidomide consolidation treatment in patients with multiple myeloma suppresses myelopoieses but spares erythropoiesis.Gene homozygosis and mitotic recombination induced by camptothecin and irinotecan in Aspergillus nidulans diploid cells.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Therapy-related myeloid malignancies in myeloma
@en
Therapy-related myeloid malignancies in myeloma.
@nl
type
label
Therapy-related myeloid malignancies in myeloma
@en
Therapy-related myeloid malignancies in myeloma.
@nl
prefLabel
Therapy-related myeloid malignancies in myeloma
@en
Therapy-related myeloid malignancies in myeloma.
@nl
P2093
P2860
P356
P1476
Therapy-related myeloid malignancies in myeloma
@en
P2093
B Barlogie
S Z Usmani
X Papanikolaou
P2860
P304
P356
10.4084/MJHID.2011.047
P577
2011-10-24T00:00:00Z